Your session is about to expire
← Back to Search
Quantifying the Venous Congestion Curve of a Tissue Oximetry Device
N/A
Waitlist Available
Led By Ramon Llull, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up hour 0.5
Awards & highlights
No Placebo-Only Group
Summary
This trial studies the effects of blood pressure cuff on tissue oxygenation in the arm & hand. A cuff is inflated, monitored every 2 min, then deflated.
Eligible Conditions
- Skin Flap Necrosis
- Postoperative Complications
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ hour 0.5
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~hour 0.5
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Transcutaneous Oximetry (StO2) of Vascular Occlusion Test at 0.5 Hours
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: ViOptix T.OxExperimental Treatment1 Intervention
ViOptix T.Ox machine is used to measure the oxygenation of composite tissue.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ViOptix
2022
N/A
~40
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,403 Previous Clinical Trials
2,478,297 Total Patients Enrolled
Ramon Llull, MDPrincipal InvestigatorWake Forest University Health Sciences
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: ViOptix T.Ox
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.